Vivo Bio Tech Ltd

VIVOBIOT

Watchlist

AI Mode

‌

Market Cap

₹ 66 Cr

P/E

16.02

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

UNDERVALUED

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Vivo Bio Tech Limited is a full-service Contract Research Organization (CRO) providing drug development and discovery services globally. It specializes in preclinical testing, offering both in-vitro and in-vivo studies.

The company has established itself as India's largest breeder and distributor of rodent models, providing SPF lab animals for preclinical studies.

Vivo Bio Tech partners with global entities like Cyagen Biosciences and Taconic to enhance genomic technologies and animal model supplies.

In 2021-22, the company expanded its scope beyond animal breeding, transforming into a comprehensive CRO focusing on various analytical and pharmacological studies.

Vivo Bio Tech is committed to quality and standards, as evidenced by its ISO 9001:2015 certification and compliance with OECD guidelines for preclinical studies.

Sector

Pharmaceuticals

Industry

Biotechnology

Market Cap

66 Cr

Volatility

Low Risk

P/E Ratio

16.0

Industry P/E

74.2

PEG Ratio

0.3

P/B Ratio

0.7

52W High

56.90

52W Low

25.21

Sales CAGR

2.68%

-3.16%

-3.35%

10Y

5.60%

Profit CAGR

187.75%

50.90%

11.24%

10Y

26.54%

ROE

TTM

4.22%

6.76%

7.43%

10Y

8.92%

ROCE

TTM

7.95%

12.92%

12.99%

10Y

13.15%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
REMUS	733.95	890 Cr	30.81	3.48	0.10	10.92	16.89	7.42
INDOUS	125.65	251 Cr	14.83	2.89	0.00	19.49	16.44	14.40
VIVOBIOT	29.74	66 Cr	16.02	0.69	0.00	4.22	7.95	2.48
SHREEGANES	0.61	24 Cr	—	0.38	0.00	0.26	0.26	0.25
TRABI	2.86	22 Cr	—	2.34	0.00	-17.64	-3.52	-1.13
VANTABIO	20.49	15 Cr	—	1.01	0.00	-23.51	-15.08	-7.97
SCAGRO	22.83	13 Cr	31.52	4.46	0.00	14.14	16.25	4.15

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	12	9.26	13	12	10	12	12	12	13	13
Expenses	7.09	4.41	6.47	6.38	5.77	6.45	6.67	7.27	7.03	7.70
Operating Profit	4.49	4.85	6.38	5.38	4.36	5.59	5.54	5.02	5.48	5.41
OPM %	38.77	52.38	49.65	45.75	43.04	46.43	45.37	40.85	43.80	41.27
Other Income	0.00	0.00	0.03	0.01	0.01	4.63	0.01	0.15	0.14	0.13
Interest	1.95	2.09	2.22	1.52	1.92	2.06	1.84	1.68	1.50	1.47
Depreciation	2.29	2.30	2.28	2.43	2.23	2.29	2.25	2.25	2.64	2.57
Profit Before Tax	0.25	0.46	1.91	1.43	0.22	5.87	1.46	1.24	1.48	1.51
Tax %	44.00	30.43	30.89	48.95	27.27	10.73	43.84	14.52	9.46	42.38
Net Profit	0.14	0.33	1.32	0.74	0.17	5.23	0.82	1.06	1.34	0.87
EPS in Rs	0.07	0.15	0.60	0.21	0.07	2.37	0.40	0.53	0.64	0.45

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	34	47	56	55	52	51	52	45	—	49
Expenses	26	36	46	43	34	36	31	24	0.00	27
Operating Profit	7.63	11	9.51	12	18	16	22	21	0.00	22
OPM %	22.35	23.15	17.04	22.53	34.11	30.77	41.17	46.40	—	44.10
Other Income	0.40	0.13	0.01	0.05	0.08	0.10	0.04	0.04	0.00	4.93
Interest	1.29	2.37	2.64	3.10	3.53	3.99	7.65	7.78	—	7.08
Depreciation	3.90	4.64	5.06	5.17	5.59	7.45	9.27	9.29	—	9.43
Profit Before Tax	2.83	4.01	1.82	4.25	8.62	4.47	4.62	4.06	—	10
Tax %	11.69	22.09	-23.20	-4.42	34.08	50.77	42.67	37.78	—	15.92
Net Profit	2.50	3.12	2.25	4.44	5.68	2.20	2.65	2.53	—	8.45
EPS in Rs	—	—	—	2.01	2.52	0.94	1.20	1.03	3.37	2.02
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9.35	9.35	9.85	12	13	13	14	15	15	—
Reserves	0.71	3.22	9.46	15	20	29	33	37	39	—
Borrowings	17	27	25	22	24	31	67	62	73	0.00
Other Liabilities	19	11	15	6.36	6.30	6.04	7.92	8.76	9.67	0.00
Total Liabilities	46	51	60	55	64	80	122	123	137	—
Fixed Assets	24	29	28	30	35	52	95	89	80	0.00
CWIP	0.04	2.96	3.94	0.07	0.15	0.32	0.87	1.90	9.21	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	22	20	28	25	29	27	26	32	48	0.00
Total Assets	46	51	60	55	64	80	122	123	137	—

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	8.81	-5.66	11	-0.78	8.61	14	17	15	16	12
Cash from Investing Activity	-7.20	-12	-4.72	-3.53	-10	-23	-51	-4.00	-7.95	-16
Cash from Financing Activity	-0.32	6.83	-3.43	0.72	2.09	8.78	35	-11	-7.56	3.90
Net Cash Flow	1.30	-11	2.96	-3.59	0.47	0.14	0.55	-0.34	0.01	-0.11

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Apr 2025	May 2025	Jun 2025	Aug 2025	Sep 2025
Promoters	42.08%	42.08%	42.08%	42.08%	42.08%	38.88%	41.57%	43.36%	42.29%	40.65%	36.43%	35.16%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	57.92%	57.92%	57.92%	57.92%	57.92%	61.12%	58.43%	56.64%	57.71%	59.35%	63.57%	64.84%
Total Shareholders	13,006	15,615	18,971	18,852	19,545	21,167	21,169	21,935	21,909	21,896	21,890	21,647

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Sep 16, 2025	Mahesh rathore	Bulk	Sell	38.00	0.41 Cr	1,08,000	0.56
May 14, 2025	Mallemkonda realities pvt	Bulk	Sell	41.20	0.85 Cr	2,06,395	1.12
May 13, 2025	Mallemkonda realities pvt	Bulk	Sell	40.27	0.38 Cr	94,307	0.51
Jan 03, 2025	Every wear import and export ...	Bulk	Sell	41.61	0.99 Cr	2,37,448	1.29
Dec 06, 2024	Vean smart infra private limited	Bulk	Sell	37.51	0.31 Cr	81,421	0.44
Nov 29, 2024	Vean smart infra private limited	Bulk	Sell	38.69	0.29 Cr	75,528	0.41

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	12	9.26	13	12	10	12	12	12	13	13
Expenses	7.09	4.41	6.47	6.38	5.77	6.45	6.67	7.27	7.03	7.70
Operating Profit	4.49	4.85	6.38	5.38	4.36	5.59	5.54	5.02	5.48	5.41
OPM %	38.77	52.38	49.65	45.75	43.04	46.43	45.37	40.85	43.80	41.27
Other Income	0.00	0.00	0.03	0.01	0.01	4.63	0.01	0.15	0.14	0.13
Interest	1.95	2.09	2.22	1.52	1.92	2.06	1.84	1.68	1.50	1.47
Depreciation	2.29	2.30	2.28	2.43	2.23	2.29	2.25	2.25	2.64	2.57
Profit Before Tax	0.25	0.46	1.91	1.43	0.22	5.87	1.46	1.24	1.48	1.51
Tax %	44.00	30.43	30.89	48.95	27.27	10.73	43.84	14.52	9.46	42.38
Net Profit	0.14	0.33	1.32	0.74	0.17	5.23	0.82	1.06	1.34	0.87
EPS in Rs	0.07	0.15	0.60	0.21	0.07	2.37	0.40	0.53	0.64	0.45

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	34	47	56	55	52	51	52	45	—	49
Expenses	26	36	46	43	34	36	31	24	0.00	27
Operating Profit	7.63	11	9.51	12	18	16	22	21	0.00	22
OPM %	22.35	23.15	17.04	22.53	34.11	30.77	41.17	46.40	—	44.10
Other Income	0.40	0.13	0.01	0.05	0.08	0.10	0.04	0.04	0.00	4.93
Interest	1.29	2.37	2.64	3.10	3.53	3.99	7.65	7.78	—	7.08
Depreciation	3.90	4.64	5.06	5.17	5.59	7.45	9.27	9.29	—	9.43
Profit Before Tax	2.83	4.01	1.82	4.25	8.62	4.47	4.62	4.06	—	10
Tax %	11.69	22.09	-23.20	-4.42	34.08	50.77	42.67	37.78	—	15.92
Net Profit	2.50	3.12	2.25	4.44	5.68	2.20	2.65	2.53	—	8.45
EPS in Rs	—	—	—	2.01	2.52	0.94	1.20	1.03	3.37	2.02
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9.35	9.35	9.85	12	13	13	14	15	15	—
Reserves	0.71	3.22	9.46	15	20	29	33	37	39	—
Borrowings	17	27	25	22	24	31	67	62	73	0.00
Other Liabilities	19	11	15	6.36	6.30	6.04	7.92	8.76	9.67	0.00
Total Liabilities	46	51	60	55	64	80	122	123	137	—
Fixed Assets	24	29	28	30	35	52	95	89	80	0.00
CWIP	0.04	2.96	3.94	0.07	0.15	0.32	0.87	1.90	9.21	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	22	20	28	25	29	27	26	32	48	0.00
Total Assets	46	51	60	55	64	80	122	123	137	—

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	8.81	-5.66	11	-0.78	8.61	14	17	15	16	12
Cash from Investing Activity	-7.20	-12	-4.72	-3.53	-10	-23	-51	-4.00	-7.95	-16
Cash from Financing Activity	-0.32	6.83	-3.43	0.72	2.09	8.78	35	-11	-7.56	3.90
Net Cash Flow	1.30	-11	2.96	-3.59	0.47	0.14	0.55	-0.34	0.01	-0.11

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
REMUS	733.95	890 Cr	30.81	3.48	0.10	10.92	16.89	7.42
INDOUS	125.65	251 Cr	14.83	2.89	0.00	19.49	16.44	14.40
VIVOBIOT	29.74	66 Cr	16.02	0.69	0.00	4.22	7.95	2.48
SHREEGANES	0.61	24 Cr	—	0.38	0.00	0.26	0.26	0.25
TRABI	2.86	22 Cr	—	2.34	0.00	-17.64	-3.52	-1.13
VANTABIO	20.49	15 Cr	—	1.01	0.00	-23.51	-15.08	-7.97
SCAGRO	22.83	13 Cr	31.52	4.46	0.00	14.14	16.25	4.15

Overview

Detailed Summary

The company has established itself as India's largest breeder and distributor of rodent models, providing SPF lab animals for preclinical studies.

Vivo Bio Tech partners with global entities like Cyagen Biosciences and Taconic to enhance genomic technologies and animal model supplies.

In 2021-22, the company expanded its scope beyond animal breeding, transforming into a comprehensive CRO focusing on various analytical and pharmacological studies.

Vivo Bio Tech is committed to quality and standards, as evidenced by its ISO 9001:2015 certification and compliance with OECD guidelines for preclinical studies.

Sector

Pharmaceuticals

Industry

Biotechnology

Market Cap

66 Cr

Volatility

Low Risk

P/E Ratio

16.0

Industry P/E

74.2

PEG Ratio

0.3

P/B Ratio

0.7

52W High

56.90

52W Low

25.21

Sales CAGR

2.68%

-3.16%

-3.35%

10Y

5.60%

Profit CAGR

187.75%

50.90%

11.24%

10Y

26.54%

ROE

TTM

4.22%

6.76%

7.43%

10Y

8.92%

ROCE

TTM

7.95%

12.92%

12.99%

10Y

13.15%

Vivo Bio Tech Ltd

Vivo Bio Tech Ltd

VIVOBIOT

AI Mode

Investment Checklist

Investment Checklist

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Projection

Actions

Announcements

Documents

AI Mode

AI Mode

Technicals

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Projection

Documents

Forecasts

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Vivo Bio Tech Ltd

VIVOBIOT

AI Mode

Peers

Price Chart Comparison

Announcements

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Investment Checklist